Sensory Enrichment for Older Adults

March 22, 2023 updated by: Michael Leon, University of California, Irvine
This study evaluates the efficacy of multi-odorant enrichment on cognitive skills, olfactory function, and quality of life.

Study Overview

Status

Terminated

Conditions

Detailed Description

The purpose of this study is to explore sensory stimulation as a potential means of enhancing cognitive abilities. In mice, multi-odorant enrichment has been shown to increase neurogenesis in a critical memory pathway and thereby improve memory. In this clinical study, we will determine if a nightly sensory enrichment regimen using scents for 6 months can improve cognitive skills, as measured using a series of cognitive assessments and brain imaging in older adults. We also will determine if mood/mental state of mind or olfactory functioning improve following scent stimulation.

This study will enroll approximately 200 participants. Of the 200 participants in the study, 50 individuals, who are interested in participating, will have a functional Magnetic Resonance Imaging (fMRI) scan at the beginning and end of the study, which will be used to examine changes in the brain.

Participants will undergo cognitive assessments, computerized cognitive assessments, and olfactory function assessments. They will be randomly assigned to either an experimental or an active control group, and will be exposed to either a higher or lower concentration of essential oils nightly using a nebulizing fragrance diffuser, rotating through seven different scents, one per night. The exposures will continue for 6 months, after which the participants will return and undergo the same assessments conducted at the beginning of the study.

Study Type

Interventional

Enrollment (Actual)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Michael Leon, PhD
  • Phone Number: 949-237-3026
  • Email: mleon@uci.edu

Study Locations

    • California
      • Irvine, California, United States, 92697
        • University of California Irvine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Are age 60-85, male or female
  2. Have normal cognition (determined at first assessment with cognitive testing)
  3. Speak/read/understand English fluently
  4. Have visual and auditory acuity adequate for neuropsychological and computerized testing
  5. Are in good general health with no disease(s) expected to interfere with the study
  6. Are willing and able to participate for the duration of the study and in all study procedures
  7. Are able to smell scents
  8. Are willing to refrain from using scented candles, scented oils, or air fresheners while participating in the study
  9. Are willing to travel to the research site for testing

    If interested in functional Magnetic Resonance Imaging (fMRI),

  10. Are willing and able to participate in the fMRI scan.

Exclusion Criteria:

  1. Have known fragrance sensitivities
  2. Have asthma, allergies, or a fragrance sensitivity, which produces symptoms similar to those of an allergy, including runny nose, watery eyes, sneezing, or skin rash
  3. Have a neurologic disease such as Parkinson's disease, multiple sclerosis, brain cyst, tumor or aneurysm
  4. Have major health conditions such as uncontrolled diabetes mellitus, uncontrolled hypertension, nutritional deficiency or thyroid disease
  5. Have significant psychiatric disorders such as schizophrenia, bipolar disorder, anxiety disorder, or attention-deficit hyperactivity disorder
  6. Have cognitive impairment when tested at baseline (defined as a score on any neuropsychological test of 1.5 standard deviations or more outside the age norm)
  7. Have had alcohol or substance abuse or dependence within the past 2 years (DSM-IV criteria)
  8. Smoke cigarettes, e-cigarettes, cigars, marijuana, or any other substance that could produce an interfering odor for the study.

    If interested in functional Magnetic Resonance Imaging (fMRI),

  9. MRI contraindications, (e.g. pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Individuals in this group receive exposure to a higher concentration of essential oil fragrances nightly.
Participants will be exposed to either a higher or lower concentration of essential oils nightly for two hours as they are going to sleep, using a nebulizing fragrance diffuser, rotating through seven different scents, one per night.
Placebo Comparator: Active control group
Individuals in this group receive exposure to a lower concentration of essential oil fragrances nightly.
Participants will be exposed to either a higher or lower concentration of essential oils nightly for two hours as they are going to sleep, using a nebulizing fragrance diffuser, rotating through seven different scents, one per night.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of behavioral pattern separation ability
Time Frame: 1) at Baseline and 2) after 6 months of intervention
Change in lure discrimination index on a computerized mnemonic discrimination task.
1) at Baseline and 2) after 6 months of intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of cognition
Time Frame: 1) at Baseline and 2) after 6 months of intervention
Change in cognitive ability will be measured using scores from a neuropsychological battery. For each subsection, a change score will be calculated using the difference between baseline and 6-month scores, and the change score will be compared between groups. Higher values indicate a better outcome.
1) at Baseline and 2) after 6 months of intervention
Evaluation of depression
Time Frame: 1) at Baseline and 2) after 6 months of intervention
Change in depression status using the Beck Depression Inventory.
1) at Baseline and 2) after 6 months of intervention
Evaluation of quality of life
Time Frame: 1) at Baseline and 2) after 6 months of intervention
Change in quality of life using the Farage Quality of Life questionnaire.
1) at Baseline and 2) after 6 months of intervention
Evaluation of olfactory function
Time Frame: 1) at Baseline and 2) after 6 months of intervention
Change from baseline score on the Sniffin' Sticks instrument to assess olfactory system functioning.
1) at Baseline and 2) after 6 months of intervention
Evaluation of change in brain structural connectivity
Time Frame: 1) at Baseline and 2) after 6 months of intervention
Change in perforant path integrity using functional Magnetic Resonance Imaging.
1) at Baseline and 2) after 6 months of intervention
Evaluation of change in brain structures
Time Frame: 1) at Baseline and 2) after 6 months of intervention
Change in thickness of entorhinal cortex using functional Magnetic Resonance Imaging.
1) at Baseline and 2) after 6 months of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 8, 2019

Primary Completion (Actual)

June 30, 2021

Study Completion (Actual)

June 30, 2021

Study Registration Dates

First Submitted

April 10, 2019

First Submitted That Met QC Criteria

April 11, 2019

First Posted (Actual)

April 16, 2019

Study Record Updates

Last Update Posted (Actual)

March 24, 2023

Last Update Submitted That Met QC Criteria

March 22, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Function

Clinical Trials on olfactory enrichment (essential oils)

3
Subscribe